# Identification of transglutaminase 2 mediated polyaminated proteins in a hepatocellular cancer cell line

**Authors:** Don Benjamin, Danilo Ritz, Sunil Shetty, Sujin Park, Michael N. Hall

PMC · DOI: 10.1016/j.csbj.2025.10.009 · 2025-10-09

## TL;DR

This study identifies proteins modified by polyamines in a liver cancer cell line, revealing their roles in cancer-related processes like translation and cytoskeleton organization.

## Contribution

The study introduces a novel method to detect and characterize polyaminated proteins using tagged polyamine analogs and mass spectrometry.

## Key findings

- 51 proteins were identified with polyamination at 66 distinct sites.
- Many modified proteins are linked to translation and cytoskeletal organization in cancer.
- Both biotin and DNP tagged polyamines were used to detect modifications.

## Abstract

Polyamines are abundant metabolites that are involved in many cellular processes. Despite playing wide-ranging and essential roles in the cell, only a few examples of a specific polyamine function are known. Polyamination is the post-translational modification of a protein by polyamines (putrescine, spermidine or spermine). This reaction is catalyzed by transglutaminases (primarily TGM2) via a transamidation reaction that conjugates a polyamine to an acceptor glutamine in a target protein. Protein polyamination is poorly characterized due to technical challenges in detecting the polyaminated adduct, and is neglected in most proteomic surveys. We performed polyamination reactions using whole cell lysates from a mouse liver cancer cell line with elevated TGM2 expression. Two differently tagged polyamine analogs (Biotin-pentylamine and DNP-pentylamine) with distinct molecular masses were used, and the respective modified peptides were identified by mass spectrometry. 51 protein targets modified on 66 different sites were identified, in some cases with both donor polyamines. Many of the targets are involved in translation or cytoskeletal organization, and implicated in cancer.

## Linked entities

- **Genes:** TGM2 (transglutaminase 2) [NCBI Gene 7052]
- **Chemicals:** putrescine (PubChem CID 1045), spermidine (PubChem CID 1102), spermine (PubChem CID 1103)
- **Diseases:** hepatocellular cancer (MONDO:0007256)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tgm2 (transglutaminase 2, C polypeptide) [NCBI Gene 21817] {aka G[a]h, TG2, TGase2, tTG, tTGas}
- **Diseases:** cancer (MESH:D009369), hepatocellular cancer (MESH:D006528)
- **Chemicals:** spermine (MESH:D013096), spermidine (MESH:D013095), glutamine (MESH:D005973), Polyamines (MESH:D011073), Biotin-pentylamine (-), putrescine (MESH:D011700)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12552909/full.md

---
Source: https://tomesphere.com/paper/PMC12552909